Showing results (21-30 of 36) with videos related to
Sort By:
Pageof 4
Journal of Clinical Medicine|February 13, 2025
RBM20 p.Arg636Cys: A Pathogenic Variant Identified in a Family with Several Cases of Unexpected Sudden DeathsRebeca Lorca, Alberto Alén, María Salgado, et al.The Annals of Pharmacotherapy|February 6, 2009
Promoting appropriate drug use through the application of the Spanish drug-related problem classification system in the primary care settingMarciana Alodia Gómez, Antonio Villafaina, Jesús Hernández, et al.Biochimica Et Biophysica Acta. Molecular Cell Research|August 12, 2019
Microenvironment-regulated lncRNA-HAL is able to promote stemness in breast cancer cellsAlfredo García-Venzor, Edna Ayerim Mandujano-Tinoco, Floria Lizarraga, et al.Nefrologia|July 4, 2024
Hypertonic saline and heart failure: "sodium-centric" or "chlorine-centric"?Jaime Mazón-Ruiz, Gregorio Romero-González, Emilio Sánchez, et al.International Journal of Cardiology|May 6, 2024
Survival analysis and gender differences in hypertrophic cardiomyopathy proband patients referred for genetic testingRebeca Lorca, María Salgado, Rut Álvarez-Velasco, et al.International Journal of Cardiology|May 18, 2026
Differences in long-term survival according to the underlying cardiomyopathy indication for implantable cardioverter-defibrillator implantationRebeca Lorca, Paula Bouzón, Fernando López, et al.Journal of Clinical Medicine|May 13, 2026
Familial Short QT Syndrome: Phenotypic Variability and Challenges in Risk StratificationPaula Bouzón, Alberto Alen, María Salgado, et al.Journal of Clinical Medicine|February 13, 2026
Exploring Sex and Clinical Factors Associated with Long-Term Survival After Implantable Cardioverter-Defibrillator Implantation: A 10-Year Cohort StudyRebeca Lorca, María Salgado, Cristina Helguera, et al.Journal of Clinical Medicine|July 29, 2023
Chromosome Y Haplogroup R Was Associated with the Risk of Premature Myocardial Infarction with ST-Elevation: Data from the CholeSTEMI RegistryRebeca Lorca, Andrea Aparicio, María Salgado, et al.The Journal of Infectious Diseases|July 3, 2023
Impact of Obefazimod on Viral Persistence, Inflammation, and Immune Activation in People With Human Immunodeficiency Virus on Suppressive Antiretroviral TherapySilvia Bernal, Maria C Puertas, Sara Morón-López, et al.Pageof 4